SINOPHARM-CICC
Sinopharm-CICC is a private equity fund focused on investments in the healthcare industry under CICC Capital.
SINOPHARM-CICC
Status:
Active
Similar Organizations
C-Bridge Capital
Cambridge Capital is a private equity fund focused on investing in the health care industry.
StarCom Group
StarCom Group is a private equity group focused on investments in the consumer sector and high-tech companies.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-18 | Zhenge Biotech | Sinopharm-CICC investment in Series C - Zhenge Biotech | 100 M CNY |
| 2022-08-02 | Xingmai Technology | Sinopharm-CICC investment in Venture Round - Xingmai Technology | 100 M CNY |
| 2020-10-06 | Hinova Pharma | Sinopharm-CICC investment in Series C - Hinova Pharma | 1000 M CNY |
| 2020-08-05 | MicuRx Pharmaceuticals | Sinopharm-CICC investment in Series D - MicuRx Pharmaceuticals | 300 M CNY |